Similar articles

• [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].

  Knauf H, Mutschler E. Knauf H, et al. MMW Munch Med Wochenschr. 1983 Nov 11;125(45):1037-40. MMW Munch Med Wochenschr. 1983. PMID: 6139750 Review. German. No abstract available.
• Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs.

  Regårdh CG. Regårdh CG. Acta Med Scand Suppl. 1982;665:49-60. doi: 10.1111/j.0954-6820.1982.tb00408.x. Acta Med Scand Suppl. 1982. PMID: 6130675 Review. No abstract available.
• Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.

  Meier J. Meier J. Cardiology. 1979;64 Suppl 1:1-13. Cardiology. 1979. PMID: 42483 No abstract available.
• The pharmacokinetic properties of beta adrenoceptor blocking drugs.

  Gugler R. Gugler R. Arch Int Pharmacodyn Ther. 1980;Suppl:27-31. Arch Int Pharmacodyn Ther. 1980. PMID: 6106455 No abstract available.
• [Genetic polymorphism of drug oxidation: its importance in the use of antihypertensive drugs].

  Dayer P. Dayer P. Nephrologie. 1981;2(4):176-7. Nephrologie. 1981. PMID: 6120476 French. No abstract available.